Business · 05/12/2019Updated: 10/17/2026 · 1 min read
FDA Announces Draft Guidance for Treatment of Interstitial Cystitis/Bladder Pain Syndrome
Summary
The FDA has released a draft guidance document outlining its recommendations for clinical trials to establish the effectiveness and safety of new drugs for treating Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →